Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-001748

President and CEO gave up 14,244 shares (to pay taxes)

  • President and CEO acquired 28,730 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-14 Exercise or conversion : show line 1 in the form +28,730 484,923 D
2020-02-14 Shares withheld for taxes : show line 2 in the form −14,244 $21.10 $300,548 470,679 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2020-02-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −28,730 $0.00 28,730 57,458 D
Loading xslF345X03/edgar.xml…